MetLife, Inc. (MET) has been a focal point for investor interest, extending from its recent share buybacks despite low Q3 earnings to lowered stock positions by M&G PLC and Geode Capital Management. Positive signs come in the form of an outperform recommendation from Keefe, Bruyette & Woods and increasing stock positions by Impax Asset Management Group and Midwest Trust Co. MET's Asia sales strength and increased capital returns mark a positive outlook, albeit a revenue miss in Q3. However, lowered stakes and sold shares are seen from National Pension Service, ProShare Advisors, AGF Management Ltd., and Savant Capital LLC. Conversely, Vise Technologies, Freemont Management, and Machina Capital made significant investments. There has been concern about MetLife's Q3 earnings and sales expectations being missed, with Q2's revenue estimates also taking a hit. Interesting developments include shareholder returns following price movement and valuation after recent market interest, MetLife's CFO John McCallion delivering a financial update on Q3, and strong Q3 earnings boosted by investment income.
Metlife MET News Analytics from Sat, 01 Mar 2025 08:00:00 GMT to Sat, 15 Nov 2025 21:32:47 GMT -
Rating 1
- Innovation -6
- Information 3
- Rumor -4
